GWM
RIGL icon

GK Wealth Management’s Rigel Pharmaceuticals RIGL Stock Holding History

GK Wealth Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$14.9K Buy
+310
New +$13.5K 0.01% 728

Other funds holding RIGL

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Venture Visionary Partners
Venture Visionary Partners Sylvania, Ohio $3.82B AUM 21.33% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GK Wealth Management's RIGL Position: Q3 2026 in Review

GK Wealth Management opened a new position in Rigel Pharmaceuticals (RIGL) in Q3 2026: 310 shares worth $14.9K. The stake represents 0.01% of the portfolio and ranks #728 among its holdings.

10 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

  • GK Wealth Management held 310 shares of Rigel Pharmaceuticals worth $14.9K as of Q3 2026.
  • Rigel Pharmaceuticals was a new GK Wealth Management position in Q3 2026.
  • Rigel Pharmaceuticals made up 0.01% of GK Wealth Management's portfolio in Q3 2026, its #728 holding.
  • 10 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on GK Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.